Deutsche Bank AG Cuts Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Key Points

• Deutsche Bank AG reduced its holdings in HealthEquity, Inc. by 5.9%, ending the quarter with 111,251 shares valued at approximately $9.83 million.
• Several hedge funds have taken significant actions regarding HealthEquity, with firms like Mirae Asset Global Investments increasing their stake by 7,983.6% during the same period.
• HealthEquity's stock currently holds a consensus rating of "Buy", with analysts raising their price targets significantly, indicating positive market sentiment.

Deutsche Bank AG decreased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.9% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 111,251 shares of the company's stock after selling 6,948 shares during the period. Deutsche Bank AG owned about 0.13% of HealthEquity worth $9,831,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. increased its position in shares of HealthEquity by 2.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 114,739 shares of the company's stock valued at $11,009,000 after acquiring an additional 3,178 shares during the last quarter. Bank of Montreal Can increased its holdings in HealthEquity by 11.7% in the fourth quarter. Bank of Montreal Can now owns 12,756 shares of the company's stock valued at $1,224,000 after purchasing an additional 1,338 shares during the period. Barclays PLC boosted its position in HealthEquity by 20.3% during the fourth quarter. Barclays PLC now owns 200,341 shares of the company's stock valued at $19,223,000 after acquiring an additional 33,849 shares during the last quarter. Mariner LLC lifted its position in HealthEquity by 1.8% in the 4th quarter. Mariner LLC now owns 13,309 shares of the company's stock valued at $1,277,000 after acquiring an additional 239 shares in the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of HealthEquity during the 4th quarter worth approximately $432,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insiders Place Their Bets

In related news, EVP Elimelech Rosner sold 58,000 shares of the company's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the sale, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. This represents a 43.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jon Kessler sold 97,767 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the completion of the transaction, the director directly owned 75,000 shares in the company, valued at approximately $8,403,750. The trade was a 56.59% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 over the last 90 days. Insiders own 1.50% of the company's stock.

HealthEquity Stock Performance

Shares of HQY stock traded up $2.46 during trading on Friday, reaching $89.89. 894,425 shares of the company's stock were exchanged, compared to its average volume of 852,047. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $7.77 billion, a PE ratio of 65.61, a PEG ratio of 1.39 and a beta of 0.54. HealthEquity, Inc. has a twelve month low of $72.79 and a twelve month high of $116.65. The firm's fifty day moving average price is $98.42 and its 200-day moving average price is $97.18.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The company had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same quarter in the prior year, the firm posted $0.80 earnings per share. As a group, sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analyst Ratings Changes

HQY has been the topic of several analyst reports. Barrington Research upped their target price on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, June 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Raymond James Financial reaffirmed a "strong-buy" rating and set a $120.00 price objective (up from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Bank of America increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.